Cargando…

Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats

BACKGROUND: Diabetes mellitus is an important risk factor for atrial fibrillation (AF) development. Sodium–glucose co-transporter-2 (SGLT-2) inhibitors are used for the treatment of type 2 diabetes mellitus (T2DM). Their cardioprotective effects have been reported but whether they prevent AF in T2DM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Qingmiao, Meng, Lei, Lee, Sharen, Tse, Gary, Gong, Mengqi, Zhang, Zhiwei, Zhao, Jichao, Zhao, Yungang, Li, Guangping, Liu, Tong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882319/ https://www.ncbi.nlm.nih.gov/pubmed/31779619 http://dx.doi.org/10.1186/s12933-019-0964-4

Ejemplares similares

Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits
por: Zhang, Xiaowei, et al.
Publicado: (2017)

Wenxin Keli Regulates Mitochondrial Oxidative Stress and Homeostasis and Improves Atrial Remodeling in Diabetic Rats
por: Gong, Mengqi, et al.
Publicado: (2020)

Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats
por: Lee, Ting-I, et al.
Publicado: (2019)

Probucol prevents atrial ion channel remodeling in an alloxan-induced diabetes rabbit model
por: Fu, Huaying, et al.
Publicado: (2016)

IP3R1/GRP75/VDAC1 complex mediates endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling
por: Yuan, Ming, et al.
Publicado: (2022)

Cilostazol ameliorates atrial ionic remodeling in long-term rapid atrial pacing dogs
por: Zhao, Zhiqiang, et al.
Publicado: (2016)

Hyperglycemia Induces Endoplasmic Reticulum Stress in Atrial Cardiomyocytes, and Mitofusin-2 Downregulation Prevents Mitochondrial Dysfunction and Subsequent Cell Death
por: Yuan, Ming, et al.
Publicado: (2020)

Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits
por: Zhang, Xiaowei, et al.
Publicado: (2018)

Sodium–Glucose cotransporter 2 inhibitor empagliflozin decreases ventricular arrhythmia susceptibility by alleviating electrophysiological remodeling post-myocardial-infarction in mice
por: Xue, Genlong, et al.
Publicado: (2022)

Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes
por: Salum, Erik, et al.
Publicado: (2012)

Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation
por: Wang, Xuewen, et al.
Publicado: (2018)

Sodium–glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway
por: Zhan, Xiaoping, et al.
Publicado: (2022)

Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus
por: Gimenes, R., et al.
Publicado: (2018)

Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study
por: Gaborit, B., et al.
Publicado: (2021)

Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat
por: Park, Sin-Hee, et al.
Publicado: (2020)

Role of Heat Shock Proteins in Atrial Fibrillation: From Molecular Mechanisms to Diagnostic and Therapeutic Opportunities
por: Liu, Daiqi, et al.
Publicado: (2022)

The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
por: Ring, Arne, et al.
Publicado: (2013)

Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-γ/PGC-1α Signaling Pathway
por: Zhang, Zhiwei, et al.
Publicado: (2021)

Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis
por: Zhang, Zhiwei, et al.
Publicado: (2017)

Xanthine Oxidase Inhibitor Allopurinol Prevents Oxidative Stress‐Mediated Atrial Remodeling in Alloxan‐Induced Diabetes Mellitus Rabbits
por: Yang, Yajuan, et al.
Publicado: (2018)

Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats
por: Lee, Kyung Ae, et al.
Publicado: (2018)

Empagliflozin prevents doxorubicin-induced myocardial dysfunction
por: Sabatino, Jolanda, et al.
Publicado: (2020)

Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes
por: Habibi, Javad, et al.
Publicado: (2017)

The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
por: Lee, Hsiang-Chun, et al.
Publicado: (2019)

The immediate trends in atrial electrical remodeling for paroxysmal atrial fibrillation across different modes of catheter ablation
por: Hou, Qian, et al.
Publicado: (2021)

Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis
por: Ashrafi Jigheh, Zahra, et al.
Publicado: (2019)

Empagliflozin Alleviates Left Ventricle Hypertrophy in High-Fat-Fed Mice by Modulating Renin Angiotensin Pathway
por: Cotrin, Juliana Cordovil, et al.
Publicado: (2022)

Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation
por: Yosefy, Chaim, et al.
Publicado: (2019)

Glucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2 weeks of tissue remodeling
por: Malfitano, Christiane, et al.
Publicado: (2015)

The effect of left atrial remodeling after cryoballoon ablation and radiofrequency ablation for paroxysmal atrial fibrillation
por: Wang, Xule, et al.
Publicado: (2020)

Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
por: Pietschner, R., et al.
Publicado: (2021)

Apocynin attenuates left ventricular remodeling in diabetic rabbits
por: Qiu, Jiuchun, et al.
Publicado: (2017)

Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca(2+) handling in smooth muscle cells
por: Ma, Yu-Guang, et al.
Publicado: (2016)

Left atrial activation and asymmetric anatomical remodeling in patients with atrial fibrillation: The relation between anatomy and function
por: Nedios, Sotirios, et al.
Publicado: (2020)

Sodium/glucose Co-Transporter 2 Inhibitor, Empagliflozin, Alleviated Transient Expression of SGLT2 after Myocardial Infarction
por: Lee, Soo Yong, et al.
Publicado: (2020)

Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy Subjects
por: Biancalana, Edoardo, et al.
Publicado: (2023)

Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin
por: Mansor, Latt S, et al.
Publicado: (2013)

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
por: Hu, Zhaoyang, et al.
Publicado: (2021)

The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
por: Oelze, Matthias, et al.
Publicado: (2014)

A Machine Learning Aided Systematic Review and Meta-Analysis of the Relative Risk of Atrial Fibrillation in Patients With Diabetes Mellitus
por: Xiong, Zhaohan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m587chslllne5omhqs06ochgs4